Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Timestamps 00:00 Intro and disclaimers (not a doctor, not a lawyer) 01:40 History: How the Biden FDA scheduled 19 peptides as Category 2 02:44 The rise of the research peptide gray market (4 out of 5 peptides) 04:18 RFK on Joe Rogan and the FDA's Category 1 plans 04:58 What Category 1 actually means (Sermorelin example) 05:42 The July hearing and February 2027 final say timeline 07:18 FDA cracking down on GLP-1s from research companies 08:42 More compounding pharmacies and telehealth clinics entering the space 09:08 The Metformin analogy and future price parity 13:20 The rug pull theory: FDA and Big Pharma quid pro quo on GLP-1s 14:04 Why Eli Lilly is protecting retatrutide (projected $50B/year product) 17:04 Final thoughts and the golden age of peptides Hunter & Taylor Answer Your Most Pressing Health Questions | Reader Mailbag Episode 1 Hunter and Taylor Williams sit down for their first ever Reader Mailbag episode a brand new deep dive Q&A format where they take the questions that need more than 60 seconds and actually break them down together
The hydroxyl groups on the terminal rings can also form mono- or diester derivatives with fatty acids, which are the predominant forms in many natural sources and further contribute to the diversity of astaxanthin compounds observed in biological systems (Nishida et al., 2023
Such interventions can vary in many key components, including the frequencies of visits
Results from these maintenance dosing studies are among the seven readouts expected in 2026
US$ 23.60
US$ 28.85
US$ 29.01
US$ 20.91
US$ 21.95
US$ 25.58
US$ 22.44
